| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:2939-2941.)
© 2004 American Heart Association, Inc.
Mini-Review: Expert Opinions |
From The Lindner Center for Research and Education/Ohio Heart Health Center (D.J.K.), Cincinnati, Ohio, and St Lukes Episcopal Hospital/Texas Heart Institute (J.T.W.), Houston, Tex.
Correspondence to Dean J. Kereiakes, MD, The Lindner Center for Research & Education, 2123 Auburn Ave, Suite 424, Cincinnati, OH 45219 (e-mail lindner{at}fuse.net), or James T. Willerson, MD, St Lukes Episcopal Hospital/Texas Heart Institute, 6720 Bertner Ave, Room B524 (MCI-267), Houston, TX 77030-2697 (e-mail suzy.lanier{at}uth.tmc.edu).
| Introduction |
|---|
|
|
|---|
At the heart of the malpractice crisis appears to be a tort system without adequate controls.9 This system has aptly demonstrated its ability to obtain large settlements in the class action case of silicone breast implants without strong scientific evidence for their harm.9 The expert opinions from noted thought leaders expressed in Circulation are remarkably passionate and consistent in their professional pride as well as commitment to compassionate, quality patient care. Our experts express hope that we are on the verge of a meaningful change in the current tort system, as well as fear of the consequences if change does not occur.
On the other hand, we also must be mindful of the fact that dedicated and well-intentioned trial lawyers are needed and that fair settlements are appropriate for patients who truly have been injured by incorrect or poorly directed actions of physicians or by potentially harmful products, the risks of which may not be represented properly by the manufacturer.
| The Problem |
|---|
|
|
|---|
The Cause
Who or what is to blame for this progressively dysfunctional system that currently threatens access to quality health care in many US states? Three potential candidates for blame have emerged: insurance carriers, healthcare providers, and trial attorneys. Each offers cogent testimony in its own defense. First, insurance carriers blame the astronomical increases in malpractice insurance premiums on massive awards to successful plaintiffs in addition to significant increments in median settlement amounts and/or the cost of defense. Drs Cline and Pepine document the increasing frequency and severity of malpractice claims and offer their state of Florida as a convincing case study. Both physicians and hospitals blame trial attorneys but also are critical of an American public that has unrealistic expectations of perfection in care and either will not or cannot differentiate between "maloccurrence" (known as adverse outcome) and malpractice (negligence). Furthermore, some juries are surprisingly poorly informed and poorly educated about many aspects of medical practice and the cumulative impact of multimillion-dollar awards on the cost of public health care. Conversely, trial attorneys are critical of both insurers and healthcare providers. They allege that insurance premiums have escalated because of irresponsible underpricing of liability insurance products by the industry during the early 1990s. Subsequent changes in insurance market competition, inflation, interest rates, stock market returns, and costs of reinsurance (in part escalated by the 9/11 tragedy) that have occurred over the past decade have "forced" the price of premiums upward. Proponents of this "insurance cycle" hypothesis point to the historically cyclic nature of the industry and argue that the problems will be self-correcting. Trial lawyers also have questioned the existence of a crisis situation that threatens public access to care when, although hospitals and physician practices are severely strained, they remain open for business. Furthermore, they point out that there are currently no studies by nonstakeholder organizations that have documented outmigration, early retirement of physicians, or closure of essential hospital services. Of note, those states that have reported few or no problems with regard to the availability of physician and/or hospital resources (most notably California and Indiana) and that are among the lowest for malpractice insurance premiums have already imposed limits or caps on noneconomic injury awards.
The Cure
"For extreme illness, extreme treatments are most fitting." Hippocrates, Aphorisms 1.6
Drs Palmisano, Cline, and Pepine are not content to wait for the insurance cycle to correct itself. The patient (ie, US health care) lies critically ill and in need of more immediate measures. They cite precedent legislative measures such as the Medical Injury Compensation Reform Act (MICRA) passed by California in 1975. They believe that similar legislative provisions (the most important of which is a cap on noneconomic damages at $250 000) would be effective in resolving the liability crisis in Florida.
Even more significantly, federal legislation that would supersede state law is in process and includes many of the line-item reforms included in MICRA. Key components of the federal Help Efficient, Accessible, Low-Cost, Timely Health Care (HEALTH) Act (H.R. 5) are as follows21: First, caps on both awards and attorneys fees are proposed. Punitive (noneconomic) damages (ie, for pain and suffering) will be capped at $250 000. Caps placed on attorneys fees will be graded and will decrease gradually from 40% of the first $50 000 of the award to 15% of the award in excess of $600 000. Second, the statute of limitations will be modified. The proposed statute of limitations requires that a suit begin within 3 years of the alleged injury or 1 year after the claimant discovers the injury (whichever occurs first). A third central element of H.R. 5 is the elimination of joint and several liability. Currently, each defendant found negligent is individually liable for the full amount of the injury. H.R. 5 limits the liability of each defendant to that share or portion of the damages attributable to his or her individual responsibility. Finally, H.R. 5 proposes to change the way that collateral source benefits are treated. Collateral source benefits are extraneous sources of compensation to which the claimant may have access in the event of injury (ie, health and disability insurance, workers compensation, life insurance, etc). Collateral source benefits will be considered during formulation of proposed rewards.
"HEALTH" Relief
The Congressional Budget Office has made several projections on the economic impact of H.R. 5. First, the caps placed on awards and attorneys fees (proximate causes of increased insurance premiums) will lower the cost of malpractice insurance coverage for physicians and other healthcare providers by an estimated 25% to 30%. In logical sequence, a reduction in charges for healthcare services and in health insurance premiums is projected to occur. Second, if employers spend less on insurance for employees, most of the employees compensation will be in the form of taxable wages and benefits. Thus, H.R. 5 is projected to increase federal revenues by $15 million in 2004 and approximately $3 billion over the years 2004 to 2013. Concurrently, the Congressional Budget Office predicts that H.R. 5 could reduce federal direct spending by approximately $14.9 billion over the same timeframe.21
| Conclusion |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Zuger A. Dissatisfaction with medical practice. N Engl J Med. 2004: 350: 6975.
3. Bonow RO, Smith SC. Cardiovascular manpower: the looming crisis. Circulation. 2004; 109: 817820.
4. Fye WB. Cardiologys workforce shortage: implications for patient care and research. Circulation. 2004; 109: 813816.
5. Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado [Comment]. Medical Care. 2000; 38: 261271.[CrossRef][Medline] [Order article via Infotrieve]
6. Thomas EJ, Studdert DM, Newhouse JP, et al. Costs of medical injuries in Utah and Colorado. Inquiry. 1999; 36: 255264.[Medline] [Order article via Infotrieve]
7. Palmisano DJ. Health care in crisis. Circulation. 2004; 109: 29332935.
8. Cline RE, Pepine CJ. Medical malpractice crisis: Floridas recent experience. Circulation. 2004; 109: 29362938.
9. Angell M. Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case. New York: W.W. Norton & Company; 1996.
10. Curran WJ, Hall MA, Bobinski M, et al. Health Care Law & Ethics. 5th ed. New York, NY: Aspen Publishers; 1998: 299.
11. Glassman PA, Rolph JE, Peterson LP, et al. Physicians personal malpractice experiences are not related to defensive clinical practices. J Health Polit Policy Law. 1996; 21: 219.
12. Perlman E. Well-managed case gets caught in malpractice fervor. American Medical News. February 21, 1994: 14.
13. US Congress, Office of Technology Assessment. Defensive Medicine and Medical Malpractice. Washington DC: US Government Printing Office; 1994. Publication OTA-H-602.
14. Novack D, Detering R, Arnold R, et al. Physicians attitudes toward using deception to resolve difficult ethical problems. JAMA. 1989; 261: 29802985.
15. Merritt, Hawkins & Associates. Summary Report: 2003 Survey of Final-Year Medical Residents. Available at: http://www.merritthawkins.com/merritthawkins/pdf/. Accessed December 8, 2003.
16. Patients, Doctors and Lawyers: Medical Injury, Malpractice Litigation and Patient Compensation in New York: Report of the Harvard Medical Practice Study to the State of New York. Cambridge, Mass; 1990.
17. Vincent C, Young M, Phillips A. Why do people sue doctors? A study of patients and relatives taking legal action. Lancet. 1994; 343: 16091613.[CrossRef][Medline] [Order article via Infotrieve]
18. Hickson GB, Clayton EW, Githens PB, et al. Factors that prompted families to file medical malpractice claims following perinatal injuries. JAMA. 1992; 267: 13591363.
19. Baylis F. Errors in medicine: nurturing truthfulness. J Clin Ethics. 1997; 8: 336340.[Medline] [Order article via Infotrieve]
20. Forster HP, Schwartz J, DeRenzo E. Reducing legal risk by practicing patient-centered medicine. Arch Intern Med. 2002; 162: 12171219.
21. H.R. 5: Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2003. Available at: http://www.cbo.gov/showdoc.cfm?index=4091&sequence=0. Accessed April 29, 2004.
This article has been cited by other articles:
![]() |
T J Papadimos Doctors as Nietzschean supermen? Author's reply Med. Humanit., June 1, 2009; 35(1): 63 - 64. [Full Text] [PDF] |
||||
![]() |
Z. N. Kain and A. A. Caldwell-Andrews What Pediatricians Should Know About Child-Related Malpractice Payments in the United States Pediatrics, August 1, 2006; 118(2): 464 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Kraus and T. A. Suarez Is There a Doctor in the House? . . . Or the Senate?: Physicians in US Congress, 1960-2004 JAMA, November 3, 2004; 292(17): 2125 - 2129. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |